InsiderClue
Insiders · Profile

Versant Venture Capital V, L.P.

10% owner at CRISPR Therapeutics. Filing since 24 Apr 2018. CIK 0001589097

Company
Date
Role
Action
Shares
Amount
Of holding
CRSP CRISPR Therapeutics AG
24 Apr 2018
10% owner
Sold, plan not stated
22,841
$1.16M
33.9%
1 decision on file.